+14,101.9%
MPWR vs GSK
+228.4%
+13,873.4%
-72.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.2% | -0.2% | +5.4% | +5.3% |
| 7D | -1.7% | +1.7% | -3.4% | -2.8% |
| 30D | -16.5% | +7.0% | -23.6% | -20.0% |
| 3M | -12.3% | -2.7% | -9.6% | -12.2% |
| 6M | -27.7% | +1.4% | -29.2% | -30.3% |
| YTD | +32.0% | +5.3% | +26.7% | +23.7% |
| 1Y | +25.1% | +10.6% | +14.4% | +13.8% |
| 3Y | +146.5% | +62.6% | +83.9% | +70.2% |
| 5Y | +126.0% | +41.7% | +84.4% | +64.9% |
| 10Y | +1,582.7% | +104.7% | +1,478.0% | +849.6% |
| All | +14,101.9% | +228.4% | +13,873.4% | +5,078.8% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling